Alkeon Capital Management
LLY icon

Alkeon Capital Management’s Eli Lilly LLY Stock Holding History

Alkeon Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-300,000
Closed -$20.7M – 61
2014
Q4 		$20.7M Buy
+300,000
New +$20.2M 0.4% 52

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Alkeon Capital Management's LLY Position: Q1 2015 in Review

Alkeon Capital Management sold out of Eli Lilly (LLY) in Q1 2015, closing a stake of 300,000 shares — an estimated $20.7M sold.

Alkeon Capital Management first reported a position in LLY in Q4 2014 and held it in 1 quarter. The position peaked at $20.7M in Q4 2014. 1,117 funds tracked by Wall St. Rank hold LLY as of Q1 2015.

  • Alkeon Capital Management reported no remaining Eli Lilly position as of Q1 2015 after selling out during the quarter.
  • Alkeon Capital Management sold 300,000 Eli Lilly shares in Q1 2015, an estimated $20.7M.
  • Alkeon Capital Management first reported a position in Eli Lilly in Q4 2014 and held it in 1 quarter.
  • Alkeon Capital Management's Eli Lilly position peaked at $20.7M in Q4 2014.
  • 1,117 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2015.

Based on Alkeon Capital Management's 13F filing for Q1 2015, filed 15 May 2015.